|3 Months Ended|
Mar. 31, 2022
|Stockholders' Equity Note [Abstract]|
The Company has authorized the issuance and sale of up to 185.0 million shares of stock, consisting of 180.0 million shares of common stock having a par value of $0.001 and 5.0 million shares of Preferred Stock having a par value of $0.001 per share. As of March 31, 2022 and December 31, 2021, there were no shares of Preferred Stock outstanding and there were no declared but unpaid dividends or undeclared dividend arrearages on any shares of the Company’s capital stock.
The Company has an incentive stock plan, the Amended and Restated 2011 Equity Incentive Plan (the “2011 Plan”), and has granted stock options to employees, non-employee directors and consultants from the 2011 Plan. Options granted under the 2011 Plan may be Incentive Stock Options or Non-statutory Stock Options, as determined by the Administrator at the time of grant. As of March 31, 2022, there were 2.9 million shares remaining available for issuance under the 2011 Plan.
During the three months ended March 31, 2022, stock options to purchase 0.4 million shares of common stock were granted at an exercise price of $0.43 per share. The stock options have a term of ten years and are subject to vesting based on continuous service of the awardee over a period of four years. The stock options have an aggregate grant date fair value of $0.1 million.
During the three months ended March 31, 2022, stock options to purchase 30,208 shares of common stock expired, were cancelled and returned to the option pool for future issuance.
The Company recorded stock-based compensation as follows:
The following table represents stock option activity for the three months ended March 31, 2022:
The following table summarizes information on stock options outstanding and exercisable as of March 31, 2022:
During the three months ended March 31, 2022, warrants to purchase 0.2 million shares of common stock expired and were cancelled.
The following table summarizes information on warrants outstanding as of March 31, 2022:
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef